Patient-reported outcomes (PROs) are a powerful tool to ensure the patient’s own voice is heard, helping clinicians and health systems deliver more patient-centered care. A new Correspondence in Nature Medicine by members of The PROTEUS Consortium describes the PROTEUS Framework…
PROTEUS and Pfizer Global Medical Grants are pleased to announce a Request for Proposals (RFP) for projects investigating the value of using patient-reported outcome measures (PROMs) in U.S. oncology clinical practice for individual patient care. Value in health care is…
PROTEUS Principal Investigator Claire Snyder, PhD, will be chairing a session at the 2023 ASCO Annual Meeting on Sunday, June 4 from 11:30 am – 12:45 pm CT. The session is titled “Patient-Reported Outcomes, Digital Health, and the Quest to…
The PROTEUS Consortium and Pfizer Global Medical Grants are forming an Advisory Group to improve the use of patient-reported outcomes (PROs) in vulnerable and underserved populations. We are seeking experts from institutions who serve vulnerable and underserved populations to attend…
The article, “Listening to the Patient Voice Adds Value to Cancer Clinical Trials,” supports “Applying Findings (Trials)” while focusing on how PROs add value to clinical trials by representing the patient voice by employing two previously published descriptive frameworks (addressing…
Continuing to expand resources and support for the optimal use of patient-reported outcomes (PRO) data in clinical trials and clinical practice, The PROTEUS Consortium has launched a new and expanded website, at ThePROTEUSConsortium.org. The website articulates a strong value proposition for…